0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Week in JAMA |

This Week in JAMA FREE

JAMA. 2006;296(13):1561. doi:10.1001/jama.296.13.1561.
Text Size: A A A
Published online

SCREENING AND SUDDEN DEATH IN ATHLETES

Preparticipation cardiac evaluation of young competitive athletes is intended to identify and disqualify those with serious cardiac abnormalities. However, the effect of such screening on sudden cardiovascular death in young athletes has not been determined. Using population-based data from Italy, where preparticipation screening of athletes was introduced in 1982, Corrado and colleaguesArticle assessed 1979-2004 trends in sudden death among athletes and nonathletes. The authors found that the incidence of sudden cardiac death in young competitive athletes declined significantly after introduction of preparticipation athlete screening, whereas rates were steady among unscreened nonathletes. In an editorial, Thompson and LevineArticle discuss the contribution of these findings to the ongoing debate about the role and components of preparticipation screening programs.

CLINICAL AND MRI CORRELATES OF CEREBRAL PALSY

To identify potential strategies to prevent cerebral palsy, Bax and colleaguesArticle reviewed clinical data and magnetic resonance imaging (MRI) brain scans obtained at 18 months of age from a cohort of children with cerebral palsy. Among the authors' findings were that maternal infection during pregnancy and multiple gestation were associated with having a child with cerebral palsy. On MRI, white matter damage of immaturity was the most common finding. In an editorial, MsallArticle discusses the findings' implications for understanding cerebral palsy syndromes, prevention, and improved patient care.

GENE POLYMORPHISMS AND ANTIDEPRESSANT RESPONSE

Genetic polymorphisms are thought to be one explanation for individual variability in response to antidepressants. In 241 Korean patients with major depression, Kim and colleagues investigated the association of genetic polymorphisms of the monoamine transporters for serotonin and norepinephrine with patient response to therapy with a selective serotonin or norepinephrine reuptake inhibitor. The authors found that the presence of certain polymorphisms, alone or in combination, was associated with response and nonresponse to therapy with serotonin or norepinephrine reuptake inhibitors.

CLINICIAN'S CORNER

Recent studies have challenged the safety of selective cyclooxygenase 2 (COX-2) inhibitors and nonselective nonsteroidal antiinflammatory drugs (NSAIDs). Two articles in this issue summarize new data on risks associated with these drugs. First, Zhang and colleaguesArticle conducted a meta-analysis of 114 controlled clinical trials of COX-2 inhibitors to evaluate the risk of adverse renal events and arrhythmias. Among their findings was that rofecoxib was associated with an increased risk of adverse renal events and arrhythmias compared with controls. McGettigan and HenryArticle conducted a meta-analysis of controlled observational studies of NSAIDs and COX-2 inhibitors to assess cardiovascular risks. Among their findings was that rofecoxib was associated with an increased risk of cardiovascular events that was evident early in treatment and was dose-related and that diclofenac is associated with increased cardiovascular risk. In an editorial, GrahamArticle discusses industry and regulatory agency contributions to the delays in identifying these risks.

A PIECE OF MY MIND

“Should I tell this man—in this impoverished and virtually inaccessible place—that he has what I believe is a tumor in the base of his brain?” From “Patagonia Pastorale.”

MEDICAL NEWS & PERSPECTIVES

The rising incidence of obesity worldwide threatens to end the steady gains in human life expectancy seen over the past 2 centuries. This week’s Medical News & Perspectives section highlights research tackling the obesity problem on several fronts.

RAPID RESPONSE TEAMS

Insufficient evidence exists to make rapid response team programs a standard of care for hospitals.

AUTHOR IN THE ROOM TELECONFERENCE

Join David Spiro, MD, MPH, Wednesday, October 18, from 2 to 3 PM eastern time to discuss wait-and-see prescription for otitis media. To register, go to http://www.ihi.org/AuthorintheRoom.

AUDIO COMMENTARY

Dr DeAngelis summarizes and comments on this week's issue. Go to http://jama.ama-assn.org/misc/audiocommentary.dtl.

JAMA PATIENT PAGE

For your patients: Information about cerebral palsy.

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...